NGF promotes neural infiltration in non-small cell lung cancer (NSCLC), while 5-hydroxytryptamine (5-HT), which is secreted by nerves, is markedly increased in tumors exhibiting extensive neural invasion. Here, NGF is linked to non-small cell lung carcinoma.